Serum levels of human immunodeficiency virus type 1 (HIV-1) RNA after seroconversion: a predictor of long-term mortality in HIV infection

J Infect Dis. 1997 Sep;176(3):798-800. doi: 10.1086/517305.

Abstract

A cohort of 79 homosexual men with documented dates of human immunodeficiency virus type 1 (HIV-1) seroconversion and baseline CD4 cell counts of > or = 500/microL were followed for up to 11.5 years. HIV-1 RNA was measured from stored sera obtained a median of 7 months after the estimated seroconversion date. AIDS progression and mortality among the men were studied, stratified by median baseline levels of HIV-1 RNA. AIDS progression rates at 11.5 years were 69% and 34%, respectively, among those with higher versus lower than median baseline virus loads (> or = 3040 copies/mL; P = .002), and mortality rates were 61% and 27%, respectively (P = .003). Survival curves continued to diverge throughout the 11.5 years, suggesting that the future clinical course of HIV-1 infection may already be determined at the earliest phases of disease. Initiation of definitive treatment very early in HIV-1 infection may be essential.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cohort Studies
  • Follow-Up Studies
  • HIV Seropositivity / blood
  • HIV Seropositivity / mortality*
  • HIV Seropositivity / virology*
  • HIV-1 / isolation & purification*
  • Homosexuality, Male
  • Humans
  • Male
  • Prognosis
  • RNA, Viral / blood*
  • Risk Factors
  • Survivors
  • Time Factors

Substances

  • RNA, Viral